PR campaigns often leverage communications trends and examples to anticipate the way  messages will play out in the mindset of their target audience.

 

Similarly, scientists and doctors alike, leverage results from human clinical trials to assess how certain diseases and medications might impact the body.

 

Therefore, when it comes to science and health, like PR, it is important to leverage trend specific data, to anticipate how certain approaches will work.

 

A recent study in the science world might be the kind of development that health professionals could leverage as they develop a thorough understanding of the human body.

 

For the first time ever, researchers from Duke University have successfully grown contracting human skeletal muscle in a laboratory. With an ability to act and respond to stimuli, this lab-grown muscle has proven through various trials to be a viable proxy for the human body. Furthermore, it holds the potential to facilitate more personalized medical treatment for patients in the need of medical tests down the road.

 

Associate professor of biomedical engineering at Duke University and one of the leaders of the study, Nenad Bursac highlighted how a development like this could significantly impact medical research by making it easier to anticipate how the body may respond to different medical treatments and procedures.

 

“The beauty of this work is that it can serve as a test bed for clinical trials in a dish,” claimed Bursac. “We are working to test drugs’ efficacy and safety without jeopardizing a patient’s health and also to reproduce the functional and biochemical signals of diseases — especially rare ones and those that make taking muscle biopsies difficult.”

 

How do you think lab-grown contracting muscle will positively shape the future of medicine? Share your thoughts below or tweet me @tamarahoumi